S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
112 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- North Bay Cancer Center
Fairfield, California, United States
- Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
- Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Aurora, Colorado, United States
- Memorial Hospital Cancer Center
Colorado Springs, Colorado, United States
- West Florida Regional Medical Center
Pensacola, Florida, United States
- Hematology Oncology Associates of Eastern Idaho
Idaho Falls, Idaho, United States
- Saint Anthony'S Hospital at Saint Anthony'S Health Center
Alton, Illinois, United States
- Cancer Care Center at St. Francis Hospital
Indianapolis, Indiana, United States
- South Central Kansas Regional Medical Center
Arkansas City, Kansas, United States
- Cancer Center of Kansas - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas - Dodge City
Dodge City, Kansas, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Cancer Center of Kansas - Kingman
Kingman, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas - Mcpherson
McPherson, Kansas, United States
- Cancer Center of Kansas - Newton
Newton, Kansas, United States
- Pratt Cancer Center of Kansas
Pratt, Kansas, United States
- Cancer Center of Kansas - Salina
Salina, Kansas, United States
- Salina Regional Health Center
Salina, Kansas, United States
- Cancer Center of Kansas - Wellington
Wellington, Kansas, United States
- Associates in Womens Health
Wichita, Kansas, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Cancer Center of Kansas, P.A. - Wichita
Wichita, Kansas, United States
- Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita, Kansas, United States
- Cancer Center of Kansas - Winfield
Winfield, Kansas, United States
- Markey Cancer Center at University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
- Louisiana State University Health Sciences Center - Monroe
Monroe, Louisiana, United States
- Tulane Cancer Center at Tulane University Hospital and Clinic
New Orleans, Louisiana, United States
- Cancer Treatment Center at Christus Schumpert St. Mary Place
Shreveport, Louisiana, United States
- Louisiana State University Health Sciences Center - Shreveport
Shreveport, Louisiana, United States
- Veterans Affairs Medical Center - Shreveport
Shreveport, Louisiana, United States
- Cancer Center at Thibodaux Regional Medical Center
Thibodaux, Louisiana, United States
- Battle Creek Health System
Battle Creek, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2003
- Primary completion
- 30 Apr 2008
- Completion
- 31 Jul 2011
- Last update posted
- 12 Sept 2017
- Registered enrollment
- 57
- Registry id
- NCT00033540
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.